Navigation Links
Mindray Medical to Attend Morgan Stanley Global Healthcare Unplugged Conference

SHENZHEN, China, Aug. 15 /Xinhua-PRNewswire-FirstCall/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide announced today that Mindray will be attending the Morgan Stanley Global Healthcare Unplugged Conference in New York, NY on September 8th & 9th, 2008.

The conference will be attended by Mr. Hang Xu, Mindray's chairman and co- chief executive officer, Joyce I-Yin Hsu, Mindray's chief financial officer, Minghe Cheng, executive vice president of strategic development, Ronald Ede, Group Vice President of International Operations, and May Li, head of investor relations. Mr. Hang Xu will be presenting on behalf of Mindray.

The Morgan Stanley Global Healthcare Unplugged Conference will take place at the Grand Hyatt New York on Monday, September 8 and Tuesday, September 9, 2008. Mr. Hang Xu will be presenting on Tuesday, September 9 at 10:20 am EST.

For more details on Morgan Stanley's Global Healthcare Unplugged Conference, please visit .

About Mindray

Mindray is a leading developer, manufacturer and marketer of medical devices worldwide. Established in 1991, Mindray offers a broad range of products across three primary business segments: patient monitoring & life support products, in-vitro diagnostic products and medical imaging systems. Mindray is globally headquartered in Shenzhen, China, with U.S. headquarters in Mahwah, New Jersey. Mindray also has another 12 international sales and service offices in Amsterdam, Frankfurt, Istanbul, London, Mexico City, Moscow, Mumbai, Paris, Sao Paolo, Seattle, Toronto and Vancouver.

For more information, please visit .

Safe Harbor Statement

This announcement contains forward-looking statements. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates," "confident" and similar statements. Statements that are not historical facts, including statements about Mindray's beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. Information regarding these risks and uncertainties is included in our public filings with the Securities and Exchange Commission. All information provided in this press release is as of July 17, 2008, and Mindray undertakes no duty to update such information, except as required under applicable law.

For investor and media inquiries, please contact:

In the U.S:

Evan Smith,


Tel: +1-212-850-5606


John Capodanno,


Tel: +1-212-850-5705


In China:

Susan Du

Mindray Medical International Limited

Tel: +86-755-2658-2518


SOURCE Mindray Medical International Limited
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Mindray Medical International Announces First Quarter 2008 Results
2. Mindray to Acquire Datascopes Patient Monitoring Business for US$202 million
3. Mindray Medical International Announces Third Quarter 2007 Results
4. Mindray Announces Appointment of Dr. Jixun Lin as Independent Director
5. Mindray to Present at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
6. China Sky One Medical, Inc. Develops Nasal Spray for Rheumatic Disease
7. Bluestar Silicones Presents Adhesive Gels for Wound Care at Medical Grade Polymers Conference
8. BioMS Medical announces positive interim analysis on phase III trial of dirucotide (MBP8298) for multiple sclerosis
9. Mentice, Inc. and the Milwaukee Area Technical College (MATC) Announce Their Partnership in the Area of Procedural Medical Simulation
10. ATS Medical to Participate at the Fourth Annual Noble Financial Equity Conference
11. BioMS Medical Announces Second Quarter 2008 Results
Post Your Comments:
(Date:6/23/2016)... SPRING, Md. , June 23, 2016 A ... collected from the crime scene to track the criminal down. ... and the U.S. Food and Drug Administration (FDA) uses DNA ... Sound far-fetched? It,s not. The ... genome sequencing to support investigations of foodborne illnesses. Put as ...
(Date:6/23/2016)... -- The Biodesign Challenge (BDC), a university competition that asks ... systems and biotechnology, announced its winning teams at the ... York City . The teams, chosen ... MoMA,s Celeste Bartos Theater during the daylong summit. Keynote ... of architecture and design, and Suzanne Lee , ...
(Date:6/23/2016)... Durham, NC (PRWEB) , ... June 23, 2016 , ... ... Odense University Hospital in Denmark detail how a patient who developed lymphedema after being ... (fat) tissue. The results could change the paradigm for dealing with this debilitating, frequent ...
(Date:6/23/2016)... 2016 On Wednesday, June 22, 2016, ... 0.22%; the Dow Jones Industrial Average edged 0.27% lower to ... down 0.17%. has initiated coverage on the following equities: ... (NASDAQ: NKTR ), Aralez Pharmaceuticals Inc. (NASDAQ: ... BIND ). Learn more about these stocks by accessing their ...
Breaking Biology Technology:
(Date:6/2/2016)... Perimeter Surveillance & Detection Systems, Biometrics & ... & Other Service  The latest report from ... of the global Border Security market . Visiongain ... billion in 2016. Now: In November 2015 ... and hardware technologies for advanced video surveillance. ...
(Date:5/16/2016)... NEW YORK , May 16, 2016   ... authentication solutions, today announced the opening of an IoT ... to strengthen and expand the development of embedded ... provides an unprecedented level of convenience and security with ... to authenticate one,s identity aside from DNA. EyeLock,s platform ...
(Date:4/28/2016)... BANGALORE, India , April 28, 2016 ... of Infosys (NYSE: INFY ), and Samsung SDS, ... partnership that will provide end customers with a more ... payment services.      (Logo: ) ... financial services, but it also plays a fundamental part in ...
Breaking Biology News(10 mins):